Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LPCN — Lipocine Inc.

CIK 72971 SAN FRANCISCO, CA
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,927
-$14,693 QoQ
Shares Held
2,706
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 36 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. LPCN ranks #328 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in LPCN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,927 2,706
2026-03-31 $21,620 2,706
2024-03-31 $218 42
2023-12-31 $114 41
2023-09-30 $116 39
2023-06-30 $186 37
2023-03-31 $194 612
2022-12-31 $239 603
2022-09-30 $264 588
2022-06-30 $2,877 3,592
2022-03-31 $4,853 3,543
2021-12-31 $4,074 4,112
2021-09-30 $4,480 4,111
2021-06-30 $1,593 1,138
2021-03-31 $1,705 1,130
2020-12-31 $582 428
2020-09-30 $566 402
2020-06-30 $267 212
2020-03-31 $101 211